Abstract
This study presents a comparative drug–protein, in vitro, binding profile of sodium aurothiomalate and auranofin. It was found that about 40% of total protein-bound gold is attached to albumin after incubation of aurothiomalate with whole blood for 24 h and about 29% of it was with α1-globulin and the least amount was found with γ-globulin (6.1%). On the other hand, approximately 84% of the protein-bound auranofin gold attached to globulins of which 51% was found with β-globulin band. It was almost equally distributed among albumin, α2-globulin and γ-globulin, and showed least affinity for α1-globulin. The gold analyses were performed by standardless instrumental neutron activation method duly validated by use of an established atomic absorption method. The results of this study explain to some extent the difference in, in vivo, pharmacokinetics and pharmacodynamics of the two drugs.
Similar content being viewed by others
References
Iqbal MS, Saeed M, Taqi SG (2008) Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate. Biol Trace Elem Res 126:56–64
Furst DE (1983) Single dose pharmacokinetics of gold compounds. Rheumatology 8:40–51
Lorber A (1981) Experience and rationale of monitoring plasma levels of gold drugs in rheumatoid arthritis. Agents Actions 8 Suppl:539–573
Danpure CJ, Fyfe DA, Gumpel JM (1979) Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compares with distribution in plasma incubated with aurothiomalate in vivo. Ann Rheu Dis 38:364–370
Gottlieb NL, Gray RG (1981) Pharmacokinetics of gold in rheumatoid arthritis. Agents Actions 8 Suppl:529–538
Bernhard GC (1982) Auranofin therapy in rheumatoid arthritis. J Lab Clin Med 100:167–177
McQueen EG, Dykes PW (1969) The transport of gold in the body. Annals of the Rheumatic Diseases. 28:437–442
Lawson KJ, Danpure CJ, Fyfa DA (1977) The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate. Biochemical Pharmacology 26:2417–2426
Danpure CJ (1974) The binding of aurothiomalate by serum proteins in vitro. Biochemical Society Transactions 2:899–901
Mascarenhas BR, Granda JL, Freyberg R H (1972) Gold metabolism in patients with rheumatoid arthritis treated with gold compounds-reinvestigated. Arthritis and Rheumatism 15:391–402
Danpure C J (1976) Interaction of aurothiomalate with human serum albumin in vitro. Biochemical Society Transactions 4:161–163
Lawrence JS(1961) Studies with radioactive gold. Annals of the Rheumatic Diseases 20; 341–361
Campion DS, OlsonR, Bohan A, Bluestone R (1974) Interaction of gold sodium thiomalate with serum albumin. Journal of Rheumatology 1:112
Ward RJ, Danpure CJ, Fyfe DA (1977) Determination of gold in plasma and plasma fractions by atomic absorption spectrometry and by neutron activation analysis. Clinica Chimica Acta 81:87–97
Lorber A, Bovy RA, Chang CC (1972) Relationship between serum gold content and distribution to serum immunologlobulins and complement. Nature New Biology 236: 250–252
Schultz DR, Gottlieb NL, Arnold PI (1973) Effects of gold on functional activities of individual complement components. Arthritis and Rheumatism 16:131
Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Mischer A (1976) New oral gold compounds for treatment of rheumatoid arthritis. Ann Rheum Dis 35:251–257
Herrlinger JD, Weikert W (1982) Protein binding of gold in serum of patients treated with different gold preparations. Z Rheumatol 415:230–234
Simonits A, De Corte F, Hoste J (1975) Single-comparator methods in reactor neutron activation analysis. J Radioanal Chem 24:31–46
De Corte F (2001) The standardization of standardless NAA. J Radioanal Nucl Chem 248:13–20
De Corte F, Simonits A (2003) At Data Nucl Data Tables 85:47
Robouch P, Arana G, Eguskiza M, Pomme S, Etxebarria N (2000) J Radioanal Chem 245:195
Kamel H, Brown DH, Ottaway JM, Smith WE (1977) Determination of gold in blood fractions by atomic absorption spectrometry using carbon rod and carbon furnace atomisation. Analyst 101:790–797
Lewis D, Capell HA, McNeil CJ, Iqbal MS, Brown DH, Smith WE (1983) Gold levels produced by treatment with auranofin and sodiumaurothiomalate. Ann Rheum Dis 42:566–570
Kushner I, Mackiewicz A (1993) The acute phase response: an overview. CRC, Boca Raton. pp. 3–19
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, M.S., Taqi, S.G., Arif, M. et al. In Vitro Distribution of Gold in Serum Proteins after Incubation of Sodium Aurothiomalate and Auranofin with Human Blood and its Pharmacological Significance. Biol Trace Elem Res 130, 204–209 (2009). https://doi.org/10.1007/s12011-009-8330-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-009-8330-0